Form 4 Tracker
Apellis Pharmaceuticals, Inc.
APLS

50 insider filings · Latest: May 14, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jan 22, 2025Jan 22 8:43 PMEisele Jeffrey
Proposed Sale
1,291$30.43$39.3K—

View →

Jan 22, 2025Jan 22 8:42 PMChopas James George
Proposed Sale
1,096$30.43$33.3K—

View →

Jan 22, 2025Jan 22 8:39 PMNicholson Nur
Proposed Sale
3,948$30.43$120.1K—

View →

Jan 17, 2025Jan 17 9:38 PMTownsend Adam J.
Proposed Sale
2,201$29.96$65.9K—

View →

Jan 17, 2025Jan 17 9:35 PMDeschatelets Pascal
Proposed Sale
750$29.96$22.5K—

View →

Jan 17, 2025Jan 17 9:32 PMNicholson Nur
Proposed Sale
2,145$29.96$64.3K—

View →

Jan 17, 2025Jan 17 9:29 PMChopas James George
Proposed Sale
715$29.96$21.4K—

View →

Jan 17, 2025Jan 17 9:27 PMFrancois Cedric
Proposed Sale
6,007$29.96$180.0K—

View →

Jan 17, 2025Jan 17 9:20 PMWatson David O.
Proposed Sale
2,201$29.96$65.9K—

View →

Jan 17, 2025Jan 17 9:18 PMBaumal Caroline
Proposed Sale
1,853$29.96$55.5K—

View →

Jan 17, 2025Jan 17 9:16 PMLewis Karen
Proposed Sale
1,241$29.96$37.2K—

View →

Jan 17, 2025Jan 17 9:16 PMSullivan Timothy Eugene
Proposed Sale
1,730$29.96$51.8K—

View →

Jan 17, 2025Jan 17 9:14 PMDeLong Mark Jeffrey
Proposed Sale
1,235$29.96$37.0K—

View →

Jan 13, 2025Jan 13 11:15 PMLewis Karen
Proposed Sale
1,627$28.70$46.7K—

View →

Jan 13, 2025Jan 13 11:13 PMSullivan Timothy Eugene
Proposed Sale
2,209$28.70$63.4K—

View →

Jan 13, 2025Jan 13 11:09 PMTownsend Adam J.
Proposed Sale
2,734$28.70$78.5K—

View →

Jan 13, 2025Jan 13 11:07 PMEisele Jeffrey
Proposed Sale
264$28.70$7.6K—

View →

Jan 13, 2025Jan 13 11:05 PMNicholson Nur
Proposed Sale
2,681$28.70$76.9K—

View →

Jan 13, 2025Jan 13 11:02 PMWatson David O.
Proposed Sale
5,056$28.70$145.1K—

View →

Jan 13, 2025Jan 13 11:02 PMFrancois Cedric
Proposed Sale
6,357$28.70$182.4K—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 14, 2026May 14 11:37 PMSinclair A. DunlopDirector
Disposition
102,826$59.860(D)

View →

May 14, 2026May 14 11:34 PMJames George ChopasVP/Chief Accounting Officer
Disposition
81,053$66.300(D)

View →

May 14, 2026May 14 11:34 PMMikael DolstenDirector
Disposition
24,135$20.960(D)

View →

May 14, 2026May 14 11:32 PMLeslie MeltzerChief Research and Development
Disposition
92,592$27.930(D)

View →

May 14, 2026May 14 11:31 PMPaul R. FonteyneDirector
Disposition
112,726$59.860(D)

View →

May 14, 2026May 14 11:30 PMTimothy Eugene SullivanChief Financial Officer
Disposition
677,390$66.300(D)

View →

May 14, 2026May 14 11:29 PMAlec MachielsDirector
Disposition
242,300$59.860(D)

View →

May 14, 2026May 14 11:27 PMPascal DeschateletsChief Scientific Officer
Disposition
588,996$66.300(D)

View →

May 14, 2026May 14 11:26 PMGerald ChanDirector
Disposition
242,300$59.860(D)

View →

May 14, 2026May 14 11:25 PMNur NicholsonChief Technical Officer
Disposition
357,594$66.300(D)

View →

May 14, 2026May 14 11:24 PMKeli WalbertDirector
Disposition
30,072$33.000(D)

View →

May 14, 2026May 14 11:23 PMMark Jeffrey DelongChief Business & Strat Officer
Disposition
235,736$66.300(D)

View →

May 14, 2026May 14 11:22 PMStephanie Monaghan O'BrienDirector
Disposition
242,300$59.860(D)

View →

May 14, 2026May 14 11:20 PMKelley BoucherChief People Officer
Disposition
146,138$28.170(D)

View →

May 14, 2026May 14 11:19 PMCraig A WheelerDirector
Disposition
42,879$25.120(D)

View →

May 14, 2026May 14 11:19 PMDavid O. WatsonGeneral Counsel
Disposition
302,965$66.300(D)

View →

May 14, 2026May 14 11:17 PMCedric FrancoisDirector, Chief Executive Officer
Disposition
1,697,706$66.300(D)

View →

May 14, 2026May 14 11:16 PMCaroline BaumalChief Medical Officer
Disposition
168,500$66.300(D)

View →

Feb 27, 2026Mar 3 9:06 PMMikael DolstenDirector
Grant/Award
24,135$20.9624,135(D)

View →

Feb 3, 2026Feb 5 9:14 PMCedric FrancoisDirector, Chief Executive Officer
Option Exercise
8,840$3.760(D)

View →